24 May 2026, Sun

N2:PHAR

N2:BACT N2:BIZ N2:CEEU N2:CMPNY N2:DE N2:DIV N2:EMEA N2:EUROP N2:EZC N2:FIN N2:GDY1 N2:HECA N2:INT N2:PHAG08 N2:PHAR N2:PHAR08 N2:PHAR1 N2:PHMR N2:PUBL N2:RES N2:RESF N2:TOPNWS N2:WEU

Bayer cuts dividends to legal minimum to reduce debt

FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its dividend policy...

N2:BIOPH N2:CMPNY N2:HEA N2:HECA N2:MRCH N2:MTPIX N2:NAMER N2:PHAR N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:US

Biogen sees flat 2024 sales, pick up in Alzheimer’s drug demand

By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product revenue...

N2:AMERS N2:BACT N2:BIZ N2:CIV N2:CLJ N2:CMPNY N2:DIABET N2:DRUGEN N2:GEN N2:GENHLT N2:HCPOL N2:HEA N2:HEAINS N2:HECA N2:INSR N2:JUDIC N2:LAW N2:MAN N2:MEDREG N2:MTPIX N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR N2:PHAR08 N2:PHAR1 N2:PHMR N2:POL N2:PUBHEA N2:PUBL N2:REGS N2:US N2:USACT

US judge refuses to block Medicare from negotiating drug prices

By Brendan Pierson (Reuters) -The U.S. government’s Medicare health insurance program can begin negotiating prices...

N2:ARTI N2:CH N2:CMPNY N2:DE N2:DRUDEV N2:EREP N2:EUROP N2:HEA N2:HECA N2:INSGHT N2:ITEC N2:MEDREG N2:MTPIX N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:SCI N2:TECH N2:US

Big Pharma bets on AI to speed up clinical trials

By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence...

N2:BLR N2:CMPNY N2:HEA N2:HECA N2:NAMER N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:RESF N2:US

J&J expects double-digit 2023 profit growth after Kenvue spinoff

(Reuters) -Johnson & Johnson on Wednesday forecast double-digit profit growth for 2023 after spinning off...

N2:BLR N2:CMPNY N2:CPROD N2:DRUDEV N2:HEA N2:HEADMI N2:HECA N2:MRCH N2:MTPIX N2:NAMER N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:RHEUMA N2:SCI N2:TOPNWS N2:US

AbbVie trims forecast for Humira sales drop on favorable coverage

By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for...

N2:ADVO N2:CMPNY N2:DEMENT N2:EREP N2:EXCLSV N2:GERIAT N2:HEA N2:HECA N2:MEDREG N2:MTPIX N2:NAMER N2:NEUROL N2:NEWS1 N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:SCI N2:US N2:WASH

Exclusive-US to build $300 million database to fuel Alzheimer’s research

By Julie Steenhuysen CHICAGO (Reuters) – The U.S. National Institute on Aging (NIA) is funding...